Clinical and pharmacodynamic biomarker results from porter, a multi-cohort phase 1 platform trial of combination immunotherapy for metastatic castration-resistant prostate cancer patients Meeting Abstract
| Authors: | Galsky, M.; Autio, K.; Wentzel, K.; Graff, J.; Friedlander, T.; Densmore, J.; Cabanski, C.; Shotts, K.; Howes, T.; Yu, J.; Eisenbeisz, E.; Spasic, M.; Maddock, S.; DaSilva, D.; Kumar, D.; Moore, J.; Schretzenmair, R.; Lata, J.; Xu, A.; Reuschel, E.; Wani, S.; Morrow, M.; Skolnik, J.; Santulli-Marotto, S.; Padron, L.; Butterfield, L.; LaVallee, T.; Bucktrout, S.; Yellin, M.; Keler, T.; Salvador, L.; O'Donnell-Tormey, J.; Lucey, V.; Fairchild, J.; Dugan, U.; Bhardwaj, N.; Subudhi, S.; Fong, L. |
| Abstract Title: | Clinical and pharmacodynamic biomarker results from porter, a multi-cohort phase 1 platform trial of combination immunotherapy for metastatic castration-resistant prostate cancer patients |
| Meeting Title: | 37th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2022) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 10 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Nov 8-12 |
| Meeting Location: | Boston, MA |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2022-11-01 |
| Start Page: | A580 |
| Language: | English |
| ACCESSION: | WOS:000919423400522 |
| DOI: | 10.1136/jitc-2022-SITC2022.0555 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 555 -- Source: Wos |
